ASPI ASP Isotopes Inc. Common Stock
ASP Isotopes Inc. Common Stock (ASPI) trend channel, buy level and 3-month target on Trade The Path. Sector: Basic Materials. Listed on NASDAQ. Levels below are fitted to this ticker's own swing highs and lows (Theil–Sen, log-price), then projected 3 months. On this symbol, 4 comparable calls have settled; 100% reached the published sell target. Information only, not financial advice.
Broken down below
Price has closed below the channel. Support has failed — treat the buy target with caution.
Read from the last 18 months of history we hold: falling, drifting −38% a year. The nearest ceiling overhead is US$4.58. What would overturn this: a close below US$3.34 — the floor of the channel being read — after which the trend, not the entry, is what was wrong.
- 18 months read from
- US$3.34 – US$4.58 Falling channel, −38% a year
- Position in that channel
- -23% below the floor of it — 0% is the floor, 100% the ceiling
What broke this trend
- The fall
- -78% from US$14.0814 Oct 2025 → 16 Sept 2026
- Whose problem it was
- This companyno peer group to compare against
- Does it resolve?
- Unsettled too close to a coin toss on the record to call
- Regained so far
- 1%of what it lost
- What the record says
- 42% of 300 comparable falls came back, typically in 176 days measured across every stock we hold history for, its peer group being too small
The trend broke in October 2025: price fell 78% from 14.08 to 3.14 by September 2026, and has regained 1% of that fall since. Its peers did not fall with it, so this was about the company rather than its sector. The wire that week: “ASP Isotopes Announces Update Featuring Its Largest-Ever Supply Agreement For Enriched Silicon-28 And Acquisition Of A U.S. Radiopharmacy To Expand And Complement Its South African Subsidiary, Pet Labs Pharmaceuticals”. What happens next is not settled: falls of about 78% here have come back to the old high 42% of the time (300 comparable falls), typically in 176 days, which is too close to a coin toss to price a recovery from.
Reported at the time: ASP Isotopes Announces Update Featuring Its Largest-Ever Supply Agreement For Enriched Silicon-28 And Acquisition Of A U.S. Radiopharmacy To Expand And Complement Its South African Subsidiary, Pet Labs Pharmaceuticals — 13 Oct 2025
Price history, with the path projected 3 months forward
- Daily close
- Upper trend line (18 months)
- Lower trend line (18 months)
- Dashed after today: projected 3 months
- Our buy
- Our target
Our target
No published call today because price has broken 3.1% below the channel floor, which is a fall out of the trend rather than a dip within it. No alerts are sent. The buy and target below are still this site's read of the fitted channel.
Buy at or below
US$2.72
level as at 19 Sept 2026
Our target
US$3.34
by 18 Dec 2026
Projected move
22.6%
gross, before costs
Price sits between our buy level and our target.
On this stock's own history these rules produced 4 settled calls, of which 4 reached target (100%), with an average best move of 13%. See the full record.
- Upper line touches
- 2
- Lower line touches
- 2
- Fit confidence
- 28%
- Fitted
- 18 Sept 2026
About ASP Isotopes Inc. Common Stock
ASP Isotopes Inc. is an emerging advanced materials company, currently in its pre-commercial stage. This firm is dedicated to the comprehensive management of isotopes, encompassing their creation, dissemination, promotion, and eventual sale. The company's developmental portfolio includes Molybdenum-100, a non-radioactive isotope designed for medical applications, alongside Carbon-14 and Silicon-28. Furthermore, ASP Isotopes is involved with Uranium-235, a specific uranium isotope considered crucial for the carbon-free energy sector. Established in 2021, the company maintains its headquarters in Boca Raton, Florida.
- Sector
- Basic Materials
- Industry
- Chemicals
- CEO
- Paul Elliot Mann
- Employees
- 271
- Country
- US
Scorecard
Our own pillar scores, computed from the fundamentals below. They are not Morningstar ratings — that data is licensed and we do not redistribute it.
- Valuation
- —
- Profitability
- —
- Financial health
- —
- Cash generation
- —
Key statistics
- Market cap
- US$491.02M
- Enterprise value
- —
- Beta
- 3.62
- Avg volume
- 4.44M
- Revenue per share
- —
- Dividend yield
- —
- 52-week range
- 3.51-14.49
- Exchange
- NASDAQ
Key ratios
- P/E (TTM)
- —
- PEG
- —
- Price / sales
- —
- Price / book
- —
- EV / EBITDA
- —
- Gross margin
- —
- Operating margin
- —
- Net margin
- —
- Current ratio
- —
- Quick ratio
- —
- Debt / equity
- —
- Interest cover
- —
Income statement
Balance sheet
Cash flow
Trend lines are fitted statistically to past swing highs and lows and projected forward on the assumption the same rhythm continues. It often does not. This is information, not advice.